From neuropathology to skin pathology, from gynaecological pathology to gastrointestinal pathology, Professor Chetty and Deciphex aim to rapidly accelerate health care standards.

In this episode of the podcast, join me, Dr Felix Beacher, as I sit down with Professor Runjan Chetty, CEO of Deciphex, a company focused on utilizing AI to improve the delivery of pathology services. Professor Chetty discusses how digitalized slides can revolutionize a global approach to pathology by enhancing medical aid and practice in remote areas.

We delve into the benefits of utilizing AI in clinical trials, and how this technology can help us develop new treatments and therapies more efficiently. Professor Chetty shares some of the challenges that come with implementing AI in the healthcare industry such as regulatory safeguarding, and preclinical approval, and offers insights into how AI is accelerating safe med tech.

Professor Chetty is the Chief Medical Officer at Diagnexia. He is an experienced Anatomical Pathologist/Histopathologist with speciality interests in GI and pancreatic pathology who has held chairs of Pathology in South Africa and Glasgow.

Original music by Felix Beacher: https://youtu.be/JS93808r-W4

Between four and five million people are diagnosed with prostate cancer every year. Lucida Medical aims to distil expert radiologists' knowledge into AI driven tech, making diagnoses repeatable at any level of medical knowledge, slashing costs, and saving lives.

Join me, Dr Felix Beacher, on today’s podcast we discuss the use of Artificial Intelligence (AI) technology in assessing prostate cancer with Dr Antony Rix, the CEO of Lucida Medical. Dr Rix shares his insights on how improving med tech capabilities can reduce backlogs of patients and needs that are straining health services. We also cover the potential to reduce misdiagnosis rates and the amount of time patients must wait for results. If you're interested in learning more about the role of AI in healthcare and the future of medical diagnosis, this podcast episode is a must-listen.

Dr Antony Rix has spent the last 30 years researching, working and building companies in artificial intelligence, signal processing and software and now works as the CEO of Lucida Medical.

His first start-up, Psytechnics (acquired 2011 by Netscout) was built on his PhD research, patents and an international standard that he helped secure. He then gained experience on medical devices and large development programmes as Senior Consultant at TTP, before returning to start-ups to found industrial sensing specialist 8power. Antony has focused on AI for cancer imaging since 2018.

Original music by Felix Beacher: https://youtu.be/JS93808r-W4